Achim Gaertner

Title: Achim Gaertner: Innovator in Antibody Conjugates

Introduction

Achim Gaertner is a notable inventor based in Bad Heilbrunn, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. His innovative work has led to the creation of a unique patent that showcases his expertise and creativity.

Latest Patents

Achim Gaertner holds a patent for "Covalently linked helicar-anti-helicar antibody conjugates and uses thereof." This patent describes a conjugate that comprises a helicar motif amino acid sequence containing compound and an antibody that specifically binds to this sequence. The invention is characterized by a covalent bond between the helicar motif amino acid sequence containing compound and an amino acid residue in the CDR2 of the anti-helicar antibody, as determined according to Kabat. This innovative approach has potential applications in various therapeutic areas.

Career Highlights

Throughout his career, Achim Gaertner has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG, where he contributed to groundbreaking research and development projects. His work in these organizations has helped advance the field of biotechnology and improve therapeutic options.

Collaborations

Achim has collaborated with esteemed colleagues, including Ulrich Brinkmann and Guy Georges. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Achim Gaertner is a distinguished inventor whose work in antibody conjugates has made a significant impact in biotechnology. His patent and collaborations reflect his commitment to advancing scientific knowledge and improving healthcare solutions.